Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Clinical Trial
. 1989 Aug;6(8):660-6.
doi: 10.1023/a:1015978104017.

Route of administration and sex differences in the pharmacokinetics of aspirin, administered as its lysine salt

Affiliations
Clinical Trial

Route of administration and sex differences in the pharmacokinetics of aspirin, administered as its lysine salt

L Aarons et al. Pharm Res. 1989 Aug.

Abstract

One thousand milligrams of aspirin, as its lysine salt was administered intravenously, orally, and intramuscularly to nine male and nine female young healthy adult volunteers. After intravenous injection mean (+/- SD) values of clearance, steady-state volume of distribution, and terminal half-life were 12.2 +/- 2.2 ml/min/kg, 0.219 +/- 0.042 liter/kg, and 15.4 +/- 2.5 min, respectively, with no differences between males and females. Following administration aspirin was absorbed more quickly in females than in males (mean absorption times of 16.4 and 21.3 min, respectively although the bioavailability, 54%, was the same in both groups. In contrast, following intramuscular administration, aspirin was absorbed more slowly in females than males (mean absorption time of 97 and 53 min, respectively) but again the bioavailability, 89%, was the same in both groups. The data suggest that in the female the intramuscular injection is going into fat. Salicylic acid concentration-time profiles showed a less pronounced sex difference and were comparable among the routes of administration.

PubMed Disclaimer

References

    1. J Pharm Sci. 1972 Mar;61(3):379-85 - PubMed
    1. J Pharmacol Exp Ther. 1946 Aug;87(4 Suppl):329-42 - PubMed
    1. Lancet. 1957 Mar 30;272(6970):657-9 - PubMed
    1. J Clin Pharmacol. 1974 Feb-Mar;14(2):77-83 - PubMed
    1. Arzneimittelforschung. 1975 Oct;25(10):1581-2 - PubMed

Publication types

LinkOut - more resources